Eisai is creating a new US corporate, R&D HQ in Roche’s old Nutley, NJ campus
Eight years after Roche pulled up stakes from Nutley, NJ in a major R&D reorganization, Japan’s Eisai is moving its US corporate and research hub into their old campus.
Now the ON3 property, Eisai — a longtime Biogen partner focused on neurodegenerative disorders like Alzheimer’s — will bring together a staff of up to 1,200 employees. And execs are pitching the move to the New Jersey campus as a cultural game-changer.
“This ON3 Eisai workplace will bring the Eisai community together in one place and drive a culture of new scientific horizons and entrepreneurial innovation,” says Tatsuyuki Yasuno, president of Eisai Inc. “We draw inspiration from our patients and passion from our people. We break barriers every day. Our workplace will too.”
Eisai is getting the 15-story office tower at 200 Metro Boulevard for the move, which they plan to complete by late 2021.
They’ll be joining a campus that already includes Quest, Hackensack Meridian Health Center for Discovery and Innovation, and Seton Hall University’s Graduate College of Nursing and School of Health and Medical Sciences.